Short term weakness will extend to Q3 and may be to Q4To be fair CRH is a good company to invest in but I will not add more until this consolidation period comes to an end. Q2 according to TD is 0.02 vs 0.04 estimated. Not much to write home about. Longs should be disappointed and $5.50 is too strong a resistant level to break through. Just like last summer all over again as I posted previously. Take note that merely record revenue is not good enough as the market sees it.
Unless there is exceptionally good news in the near term to change the picture CRH will trade in a range. Patience is required.